11β-Hydroxysteroid dehydrogenase: a relevant determinant of gluco- and mineralocorticoid-actions

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Clinical Investigation

• Publication date

  1994-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/BF00212994
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• [Syndrome of apparent mineralocorticoid excess].

  2005cited by this paper
• 11 beta-Hydroxysteroid dehydrogenase accounts for low prednisolone/prednisone ratios in the kidney.

  1994cited by this paper
• Pharmacology of 11β-hydroxysteroid dehydrogenase

  1994cited by this paper
• 11β-Hydroxysteroid dehydrogenase activity and corticosteroid hormone action

  1994cited by this paper
• Enzymes and receptors: challenges and future directions.

  1994cited by this paper
• 11 beta-hydroxysteroid dehydrogenase.

  1993cited by this paper
• Tissue-specific distribution of the NAD(+)-dependent isoform of 11 beta-hydroxysteroid dehydrogenase.

  1992cited by this paper
• Localization of an 11 beta hydroxysteroid dehydrogenase activity to the distal nephron. Evidence for the existence of two species of dehydrogenase in the rat kidney.

  1992cited by this paper
• Potentiation of hydrocortisone activity in skin by glycyrrhetinic acid.

  1990cited by this paper
• Cloning and expression of rat cDNA encoding corticosteroid 11 beta-dehydrogenase.

  1989cited by this paper
• Syndrome of apparent mineralocorticoid excess. A defect in the cortisol-cortisone shuttle.

  1988cited by this paper
• Purification and Characterization of the Corticosteroid 1lβ-Dehydrogenase Component of the Rat Liver 1lβ-Hydroxysteroid Dehydrogenase Complex*

  1988cited by this paper

• No citing papers are available for this paper.